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Oral anticoagulant monitoring has traditionally been hospital based, in part because of the need for a laboratory blood test. The growing numbers of patients receiving warfarin as a result of the increasing indications for anticoagulation-especially for non-rheumatic atrial fibrillation-have led to pressure on primary care to undertake therapeutic monitoring. 1 2 If this shift of care is to occur, it is important that the international normalised ratio (INR) can be reliably measured within primary care settings.
There are two potential obstacles to ensuring reliability: the provision of adequately trained personnel and the availability of suitable technology. The traditional belief has been that trained laboratory staV are needed to perform the test because of the complex operator dependent steps and the requirements of quality assurance. 3 Concerns are expressed that laboratory testing within general practice settings is done poorly, and this issue would be particularly important for a test which results in treatment change. 4 Several portable instruments are available for INR estimation outside laboratory settings. These show good reliability in comparison with traditional laboratory techniques 5 6 ; however, evaluations have only been performed in hospital settings using highly trained staV, with few data from primary care. 7 The aim of anticoagulant treatment is to prevent thrombotic problems, while minimising the risks of bleeding caused by depression of clotting factors. 8 Recognition of the haemorrhagic side eVects of warfarin led to the development of the prothrombin time test for monitoring anticoagulant activity. 9 The prothrombin time assesses the integrity of the extrinsic coagulation pathway including three of the clotting factors dependent upon vitamin K (factors II, VII, and X). The prothrombin time may vary, however, according to the specific thromboplastin used, with less sensitive thromboplastins giving a shorter prothrombin time. 10 The INR system, established as an attempt to standardise these discrepancies, is based on a quantitative assessment of the responsiveness of a thromboplastin by comparison with reference thromboplastins from the World Health Organisation (WHO). 11 12 13 In this paper we investigate the reliability of INRs performed in primary care in comparison with parallel results obtained in hospital laboratories using the same samples.
Methods
As part of an MRC funded health technology assessment to investigate the possibility of transferring oral anticoagulant monitoring from secondary to primary care, a network of nine general practices was developed to manage warfarin patients using computerised decision support (CDSS) and near patient testing (NPT) for INR. This study was undertaken from 1 February 1995 until 31 January 1996. Thrombotrak (Nycomed UK) was used as the NPT, being the only instrument at the time that had undergone a positive UK Department of Health evaluation. The thromboplastin reagent used was Thrombotest (Nycomed UK), a WHO secondary reference thromboplastin with manufacturer's derived ISI of 1.0. The same batch of Thrombotest was used throughout the study.
To perform the INR test a venous sample of blood was collected in a citrated tube; 50 µl of this sample were added to 250 µl of reconstituted reagent, warmed to 37°C. Internal quality assurance (IQA) was performed before starting each practice clinic, with external quality assurance (EQA) performed every eight to 12 weeks. Both IQA and EQA were provided through the local reference laboratory (laboratory 1).
The remaining portions of the venous samples were sent to three local laboratories, which used four diVerent methods to compare the INR results obtained. Blood samples were delivered to the hospitals by routine collection. In laboratory 1 the INR was estimated on two machines: Thrombotrak using Thrombotest from the same batch as that used by the practices (method 1a); and by ACL machine (Instrumentation Laboratory, UK, Ltd) using IL (PT-Fibrinogen HS plus) reagent (method 1b). The ISI of the ACL/IL combination was derived by the laboratory using an orthogonal regression calibration procedure, comparing manual and machine values obtained from 20 normal and 80 warfarinised patient plasmas, resulting in a value of 1.15. As laboratory 1 is recognised by the health authority as a regional reference laboratory, the INR derived using the ACL/IL combination is taken as the gold standard (method 1b).
In laboratory 2, INR was estimated by KC-10 machine using Manchester reagent, ISI 1.04 (method 2). In laboratory 3, INR was performed manually using Manchester reagent, ISI 1.03 (method 3). These ISIs were provided by the manufacturer, with no local calibration undertaken. All three laboratories participated in two external quality assurance schemes-NEQAS (national external quality assessment scheme) and CEQAS (central external quality assurance scheme). Five practices sent samples to laboratory 1, four practices sent samples to laboratory 2, with one of these practices changing to laboratory 3 during the study.
All practice based clinics were run by nurses, except for one which employed a medical laboratory scientific oYcer (MLSO) for the study. All practice based staV attended a one day training course which dealt with the theoretical aspects of oral anticoagulation as well as practical training in the use of CDSS and NPT. On site support was available for the first three clinics, although this was primarily needed for CDSS interpretation and clinical advice rather than help in performing the INR. were 54% for laboratory 1, 52% for laboratory 2, and 54% for laboratory 3. Tables 1-4 outline the numbers of tests whereby a clinically significant diVerence would have arisen depending on where the test was performed (that is, where practice and laboratory results are discrepant for in-range values). Sensitivity in this instance is defined as the proportion of results from the same sample being within the individual therapeutic range on both methods being compared; specificity is defined as the proportion of results being outside the therapeutic range using both methods. Although the correlation between the practice results and laboratory 1 Thrombotrak results is very good, there is a small positive bias of 0.28 on average in the practice results. The correlation between practice and laboratory 1 ACL shows that the practice INRs are consistently higher than the laboratory results, by 0.41 on average. There is a similar but greater discrepancy for laboratory 2 KC-10 ( fig  1) , where the mean bias was 0.56, and laboratory 3 manual, where the mean bias was 0.59. In all three cases bias tended to become greater as the INR increased. The predicted mean bias at an INR of 4.0 would be 0.48, 0.91, and 1.55, respectively.
Discussion
This study has highlighted the problems of varying INR results from the same blood sample. The implications of this are of great importance given the increasing pressure on primary care to undertake therapeutic monitoring of oral anticoagulation. We have shown that up to 50% of dosing decisions may be made diVerently according to the method of INR determination. This is a highly clinically significant finding since over and under dosing of warfarin can carry substantial risk.
The INR system was designed to overcome these diVerences and provide consistency in the measurement of the therapeutically induced coagulation defect, regardless of the method or site of testing. On these data, patients being monitored through two laboratories (2 and 3) would require larger warfarin doses to achieve therapeutic INRs than patients being monitored by either laboratory 1 or in primary care. One possible explanation for the variation in comparative INR measurements will be inadequate performance within the laboratory, to a level that falls below quality assurance programmes. All of the laboratories in this trial were subject to at least one external quality assurance programme (all were under NEQAS), but the results of their performance are not available to the authors since this is a confidential inquiry. However, clearly one possible explanation for the discrepancies in comparative INR measurements could have been that the performance in one or all of the clinics fell below the EQA standard.
Naturally, this does not negate the findings of this study (because it measures actual practice), but it may provide a further explanation for the variation in levels. This possibility reinforces the essential involvement of any centre performing diagnostic testing, whether in primary or secondary care, to join an appropriate EQA scheme. These primary care data reconfirm laboratory findings that the INR is influenced by the reagent used to measure it. [15] [16] [17] These data also show that the INR system does not adequately standardise for the diVerent methods of testing, although the factors leading to this are probably multiple. The derivation of the ISI is currently performed against diVerent WHO reference materials which may be one source of error. The diVering thromboplastins used have varying sensitivities which are not fully accommodated by the INR.
This study is the first primary care based study of INR reliability. The results, particularly the correlation between results derived using the same technology, indicate that trained primary care nurses can perform the INR test as well as experienced laboratory staV. If primary care is to become more involved with therapeutic monitoring of oral anticoagulation, it is important that close links are forged between pathology laboratories and practices to ensure that diVerences in INR results obtained are kept to a minimum, with internal and external quality assurance procedures being organised through the local laboratory. In turn, hospital laboratories must adopt more consistent methods of INR estimation if their recommendations are to be reliable. The INR can be measured as consistently and safely in general practices as in hospital laboratories. The validity of derived INR results is as much a problem in hospital settings as in primary care and requires further investigation of the causes.
